1.The Role of Innate and Adaptive Immune Cells in the Immunopathogenesis of Chronic Obstructive Pulmonary Disease.
Fariz NURWIDYA ; Triya DAMAYANTI ; Faisal YUNUS
Tuberculosis and Respiratory Diseases 2016;79(1):5-13
Chronic obstructive pulmonary disease (COPD) is a chronic and progressive inflammatory disease of the airways and lungs that results in limitations of continuous airflow and is caused by exposure to noxious gasses and particles. A major cause of morbidity and mortality in adults, COPD is a complex disease pathologically mediated by many inflammatory pathways. Macrophages, neutrophils, dendritic cells, and CD8+ T-lymphocytes are the key inflammatory cells involved in COPD. Recently, the non-coding small RNA, micro-RNA, have also been intensively investigated and evidence suggest that it plays a role in the pathogenesis of COPD. Here, we discuss the accumulated evidence that has since revealed the role of each inflammatory cell and their involvement in the immunopathogenesis of COPD. Mechanisms of steroid resistance in COPD will also be briefly discussed.
Adult
;
Dendritic Cells
;
Humans
;
Lung
;
Lymphocytes
;
Macrophages
;
Mortality
;
Neutrophils
;
Pulmonary Disease, Chronic Obstructive*
;
RNA
;
T-Lymphocytes
2.Strategies for an effective tobacco harm reduction policy in Indonesia.
Fariz NURWIDYA ; Fumiyuki TAKAHASHI ; Hario BASKORO ; Moulid HIDAYAT ; Faisal YUNUS ; Kazuhisa TAKAHASHI
Epidemiology and Health 2014;36(1):e2014035-
Tobacco consumption is a major causative agent for various deadly diseases such as coronary artery disease and cancer. It is the largest avoidable health risk in the world, causing more problems than alcohol, drug use, high blood pressure, excess body weight or high cholesterol. As countries like Indonesia prepare to develop national policy guidelines for tobacco harm reduction, the scientific community can help by providing continuous ideas and a forum for sharing and distributing information, drafting guidelines, reviewing best practices, raising funds, and establishing partnerships. We propose several strategies for reducing tobacco consumption, including advertisement interference, cigarette pricing policy, adolescent smoking prevention policy, support for smoking cessation therapy, special informed consent for smokers, smoking prohibition in public spaces, career incentives, economic incentives, and advertisement incentives. We hope that these strategies would assist people to avoid starting smoking or in smoking cessation.
Adolescent
;
Body Weight
;
Cholesterol
;
Coronary Artery Disease
;
Financial Management
;
Harm Reduction*
;
Hope
;
Humans
;
Hypertension
;
Indonesia*
;
Informed Consent
;
Motivation
;
Practice Guidelines as Topic
;
Smoke
;
Smoking
;
Smoking Cessation
;
Tobacco Products
;
Tobacco Use
;
Tobacco*
3.Molecular Diagnosis of Tuberculosis
Fariz NURWIDYA ; Diah HANDAYANI ; Erlina BURHAN ; Faisal YUNUS
Chonnam Medical Journal 2018;54(1):1-9
Tuberculosis (TB) is one of the leading causes of adult death in the Asia-Pacific Region, including Indonesia. As an infectious disease caused by Mycobacterium tuberculosis (MTB), TB remains a major public health issue especially in developing nations due to the lack of adequate diagnostic testing facilities. Diagnosis of TB has entered an era of molecular detection that provides faster and more cost-effective methods to diagnose and confirm drug resistance in TB cases, meanwhile, diagnosis by conventional culture systems requires several weeks. New advances in the molecular detection of TB, including the faster and simpler nucleic acid amplification test (NAAT) and whole-genome sequencing (WGS), have resulted in a shorter time for diagnosis and, therefore, faster TB treatments. In this review, we explored the current findings on molecular diagnosis of TB and drug-resistant TB to see how this advancement could be integrated into public health systems in order to control TB.
Adult
;
Communicable Diseases
;
Developing Countries
;
Diagnosis
;
Diagnostic Tests, Routine
;
Drug Resistance
;
Humans
;
Indonesia
;
Mycobacterium tuberculosis
;
Nucleic Acid Amplification Techniques
;
Public Health
;
Tuberculosis
;
Tuberculosis, Multidrug-Resistant
4.Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
Fariz NURWIDYA ; Jamal ZAINI ; Andika Chandra PUTRA ; Sita ANDARINI ; Achmad HUDOYO ; Elisna SYAHRUDDIN ; Faisal YUNUS
Chonnam Medical Journal 2016;52(3):151-158
Circulating tumor cells (CTCs) are tumor cells that are separated from the primary site or metastatic lesion and disseminate in blood circulation. CTCs are considered to be part of the long process of cancer metastasis. As a 'liquid biopsy', CTC molecular examination and investigation of single cancer cells create an important opportunity for providing an understanding of cancer biology and the process of metastasis. In the last decade, we have seen dramatic development in defining the role of CTCs in lung cancer in terms of diagnosis, genomic alteration determination, treatment response and, finally, prognosis prediction. The aims of this review are to understand the basic biology and to review methods of detection of CTCs that apply to the various types of solid tumor. Furthermore, we explored clinical applications, including treatment monitoring to anticipate therapy resistance as well as biomarker analysis, in the context of lung cancer. We also explored the potential use of cell-free circulating tumor DNA (ctDNA) in the genomic alteration analysis of lung cancer.
Biology
;
Blood Circulation
;
Diagnosis
;
DNA
;
DNA, Neoplasm
;
Lung Neoplasms
;
Lung
;
Methods
;
Neoplasm Metastasis
;
Neoplastic Cells, Circulating
;
Prognosis